Manchester Capital Management LLC Catalent, Inc. Transaction History

Manchester Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$32.18 - $46.57 $4,633 - $6,706	144 New	144 $6,000
Q1 2023 May 09, 2023	BUY	$45.44 - $74.26 $51,120 - $83,542	1,125 Added 1041.67%	1,233 $81,000
Q4 2022 Feb 09, 2023	SELL	$41.39 - $81.0 $36,092 - $70,632	-872 Reduced 88.98%	108 $4,000
Q4 2021 Feb 10, 2022	BUY	$119.57 - $139.07 $13,750 - $15,993	115 Added 13.29%	980 $125,000
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $94,432 - $123,132	865 New	865 $115,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Manchester Capital Management LLC with notifications on news.